🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open label, phase 1 study for AML subjects with relapsed or refr...
Status
Recruiting
Location
University of Colorado Hospital
Start Date
2024-07-21
Trial ID
NCT06429449
Treatments Being Tested
A Phase 1/2a study to assess the safety, tolerability, PK and biological ac...
Status
Recruiting
Location
Emory Winship Cancer Institute
Start Date
2019-08-09
Trial ID
NCT04068597
This study will be conducted in two parts. Part 1 will be the Dose Confirma...
Status
Completed
Location
Mitchell Cancer Institute /ID# 216443
Start Date
2020-03-26
Trial ID
NCT04102020
Treatments Being Tested
To assess the safety and efficacy of galinpepimut-S (GPS) compared with inv...
Status
Active Not Recruiting
Location
O'Neal Comprehensive Cancer Center
Start Date
2021-02-08
Trial ID
NCT04229979
Treatments Being Tested
This phase II trial evaluates the effect of azacitidine or decitabine and v...
Status
Recruiting
Location
UCSF-Fresno
Start Date
2022-02-09
Trial ID
NCT04905810
Treatments Being Tested
Primary Objective: 1\. To evaluate whether 5 azacytidine (5-aza)/valproic ...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2005-08
Trial ID
NCT00382590
Treatments Being Tested
The goal of this clinical trial is to compare the efficacy and safety of a ...
Status
Recruiting
Location
the First Affiliated Hosptital of Soochow University
Start Date
2026-02-01
Trial ID
NCT07425782
Treatments Being Tested
This trial is evaluating the safety and tolerability of venetoclax with che...
Status
Recruiting
Location
University of California San Francisco-Benioff Children's Hospital
Start Date
2023-03-29
Trial ID
NCT05292664
Figure out the Efficacy and Safety of Azacitidine Combined with BUCY2 Condi...
Status
Unknown
Location
Multiple Locations
Start Date
2024-03-01
Trial ID
NCT06279338
Treatments Being Tested
This study will enroll participants with myelodysplastic syndromes (MDS) wi...
Status
Recruiting
Location
Presbyterian / St. Luke'S Medical Center
Start Date
2024-12-03
Trial ID
NCT06465953
Treatments Being Tested